{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-146147","form_type":"8-K","ticker":"SPRY","cik":"0001671858","company_name":"ARS Pharmaceuticals, Inc.","filed_at":"2023-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.966026+00:00","generated_at":"2026-06-14T23:48:12.565844+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"ARS Pharmaceuticals releases revised corporate presentation highlighting its needle-free epinephrine device","bullets":["ARS Pharmaceuticals released a revised corporate presentation on May 16, 2023.","Presentation highlights the company's needle-free epinephrine product for allergic reactions.","No earnings, clinical results, or regulatory milestones were disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-146147","json":"https://secwatch.observer/filing/0001193125-23-146147.json","markdown":"https://secwatch.observer/filing/0001193125-23-146147.md","text":"https://secwatch.observer/filing/0001193125-23-146147.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671858/000119312523146147/0001193125-23-146147-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671858/000119312523146147/d434574d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T23:48:12.565844+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}